[Dysplastic melanocytic nevus]
- PMID: 21171474
[Dysplastic melanocytic nevus]
Abstract
The dysplastic melanocytic nevus remains an issue of controversy despite extensive investigations. On clinical grounds the term atypical melanocytic nevus should be used, while dysplastic melanocytic nevus describes histological characteristics. The association with melanoma is complex. With the clinical picture, dermatoscopy and molecular biological or genetic examinations one can often not distinguish a histological dysplastic nevus from a melanoma. In patients with large amounts of melanocytic nevi it is important to assess the total melanoma risk, the need for patient surveillance and motivate the patient for self-examination. In high-risk patients the amount of benign melanocytic nevi is increased and many clinically atypical and microscopically dysplastic nevi can be found. The relatives of these patients should also be examined. Because of the rising incidence of melanoma and the lack of therapeutic options in disseminated disease, the surveillance of high risk patients, the early detection of melanoma and excision play a key role in patient management.
Similar articles
-
Dysplastic nevus: why this term should be abandoned in dermatoscopy.Dermatol Clin. 2013 Oct;31(4):579-88, viii. doi: 10.1016/j.det.2013.06.009. Epub 2013 Jul 23. Dermatol Clin. 2013. PMID: 24075546 Review.
-
[Management of acquired nevus-cell nevi in clinical practice].Ther Umsch. 1989 Feb;46(2):133-7. Ther Umsch. 1989. PMID: 2928982 German.
-
Dermoscopy: basic concepts.Int J Dermatol. 2008 Jul;47(7):712-9. doi: 10.1111/j.1365-4632.2008.03556.x. Int J Dermatol. 2008. PMID: 18613881 Review.
-
Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.Arch Dermatol. 2005 Aug;141(8):998-1006. doi: 10.1001/archderm.141.8.998. Arch Dermatol. 2005. PMID: 16103329
-
[Pigment nevi in children].Hautarzt. 2010 May;61(5):443-51; quiz 452. doi: 10.1007/s00105-010-1952-5. Hautarzt. 2010. PMID: 20437126 German.
Cited by
-
α-Methylacyl-coenzyme A racemase (AMACR, p504s) is a marker to distinguish malignant melanomas from dysplastic nevi and melanocytic nevi.Tumour Biol. 2014 Dec;35(12):12015-20. doi: 10.1007/s13277-014-2500-1. Epub 2014 Aug 24. Tumour Biol. 2014. PMID: 25149154
-
Novel multiple markers to distinguish melanoma from dysplastic nevi.PLoS One. 2012;7(9):e45037. doi: 10.1371/journal.pone.0045037. Epub 2012 Sep 27. PLoS One. 2012. PMID: 23028750 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical